Astellas Pharma Europe Limited
Stories about Astellas
- Language:
-
Media:
All
- Period:
- Period:Total
- more
Astellas Pharma Europe Limited
Britain Facing Social Care 'Time-bomb' with Thousands of People Underprepared to Look After Themselves in Old Age
moreAstellas Pharma Europe Limited
Astellas Announces New Enzalutamide Data Presented During Plenary Presentations at the 2015 European Association of Urology Congress
moreAstellas Pharma Europe Limited
Medivation and Astellas Announce the Phase 3 PREVAIL Trial of XTANDI?(TM) (Enzalutamide) Meets Both Co-Primary Endpoints of Overall Survival and Radiographic Progression-Free Survival in Chemotherapy-Naïve Patients with Advanced Prostate Cancer
moreAstellas Pharma Europe Limited
Astellas Pharma Inc.: Announcement of Regulatory Submission for Mirabegron (YM178), a Treatment for Overactive Bladder, in U.S. and Europe
moreAstellas Pharma Europe Limited
Astellas Receives Positive Opinion From CHMP for European Approval of VIBATIV(TM) for Nosocomial Pneumonia Caused by MRSA
moreAstellas Pharma Europe Limited
Urology and Transplantation Will Drive Future Growth as Astellas Begins Move into Oncology
moreAstellas Pharma Europe Limited
Advagraf(R) Now Approved Across Europe as a Once-Daily Immunosuppressant in Organ Transplantation
more
1